Discordance between commercial genotyping platforms for APOE polymorphisms in Libyan patients with coronary heart disease: a methodological pilot study
Year: 2026
Type: article
Abstract: Commercial APOE genotyping platforms are widely used in cardiovascular genetic studies, but their performance in genetically understudied populations is rarely verified. This pilot study compared a reverse-hybridization strip assay and a real-time PCR (qPCR) kit for APOE genotyping (rs429358 and rs7412) in Libyan participants and examined how their calls disagreed. In a validation subset of 28 individuals, the strip assay gave no valid result in 5 (17.9%). Among the 23 samples valid on both platforms, genotype concordance was 8/23 (34.8%; 95% CI 18.8–55.1%) and Cohen’s κ was 0.19 (slight agreement). Single-SNP agreement was 65.2% for rs429358 and 60.9% for rs7412. The strip assay consistently reported more minor alleles than qPCR, but without a sequencing reference standard it is unknown which platform is correct. APOE genotype frequencies in Libyan patients with coronary heart disease could therefore not be reliably determined; strip-derived calls for 60 patients are provided only as unverified, exploratory data (Additional file 1). Sequencing confirmation should precede any larger APOE association study in this population.
Source: BMC Research Notes
Language: English
Subfield: Genetics
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $1,690
OpenAlex ID: W7236157674
